Dutrebis Interactions
There are 115 drugs known to interact with Dutrebis (lamivudine / raltegravir), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 26 are major, 58 are moderate, and 31 are minor.
- View Dutrebis alcohol/food interactions (1)
- View Dutrebis disease interactions (8)
Medications known to interact with Dutrebis
Note: Showing generic names only.
- aluminum carbonate
- aluminum hydroxide
- amprenavir
- apalutamide
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- atidarsagene autotemcel
- cabozantinib
- calaspargase pegol
- calcium carbonate
- cannabidiol
- capivasertib
- carbamazepine
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cimetidine
- cladribine
- clofarabine
- cobicistat
- efavirenz
- elivaldogene autotemcel
- emtricitabine
- epirubicin
- esomeprazole
- etranacogene dezaparvovec
- etravirine
- magaldrate
- magnesium amino acids chelate
- magnesium aspartate
- magnesium carbonate
- magnesium chloride
- magnesium citrate
- magnesium gluconate
- magnesium glycinate
- magnesium hydroxide
- magnesium lactate
- magnesium malate
- magnesium oxide
- magnesium salicylate
- magnesium sulfate
- magnesium taurate
- magnesium threonate
- mannitol
- methotrexate
- mipomersen
- pantoprazole
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- phenobarbital
- phenytoin
- pioglitazone
- pitolisant
- primidone
- rabeprazole
- ranitidine
- ranitidine bismuth citrate
- remdesivir
- ribavirin
- rifabutin
- rifampin
- rifapentine
- ritonavir
- rucaparib
Dutrebis alcohol/food interactions
There is 1 alcohol/food interaction with Dutrebis (lamivudine / raltegravir).
Dutrebis disease interactions
There are 8 disease interactions with Dutrebis (lamivudine / raltegravir) which include:
- hepatitis B
- hepatotoxicity
- pancreatitis
- renal dysfunction
- hemodialysis
- liver disease
- myopathy/rhabdomyolysis
- PKU
More about Dutrebis (lamivudine / raltegravir)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.